Effect of BMP-2 and/or BMP-9 on preosteoblasts attached to polycaprolactone functionalized by adhesive peptides derived from bone sialoprotein

Biomaterials

Volumn 34, Issue 4, 2013, Pages 1051-1062

  Drevelle, Olivier ^a   Daviau, Alex ^a   Lauzon, Marc Antoine ^a   Faucheux, Nathalie ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Alkaline phosphatase; Cell activation; Cell signalling; Gene expression; RGD peptide

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE ACTIVITY; BONE MORPHOGENETIC PROTEINS; BONE SIALOPROTEINS; CELL ACTIVATION; CELL SIGNALLING; FUNCTIONALIZED; GROWTH FACTOR; MC3T3-E1; OSTEOCALCIN; OSTERIX; PREOSTEOBLASTS; RGD PEPTIDE;

BIOMATERIALS; CELLS; GENE EXPRESSION; PEPTIDES; PHOSPHATASES; PHOSPHORYLATION; POLYCAPROLACTONE; SIGNAL TRANSDUCTION;

CYTOLOGY;

ALKALINE PHOSPHATASE; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 9; BONE SIALOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; POLYCAPROLACTONE; SMAD PROTEIN; TRANSCRIPTION FACTOR DLX5;

ANIMAL CELL; ANTIBODY LABELING; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; NONHUMAN; OSTEOBLAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADHESIVENESS; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEIN 2; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; GROWTH DIFFERENTIATION FACTOR 2; INTEGRIN-BINDING SIALOPROTEIN; MICE; OLIGOPEPTIDES; OSTEOBLASTS; POLYESTERS; STEM CELLS;

MURINAE;

EID: 84870362553     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.10.066     Document Type: Article

References (42)

1. Al-Aql Z.S., Alagl A.S., Graves D.T., Gerstenfeld L.C., Einhorn T.A. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 2008, 87:107-118.
2. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
3. Urist M.R., Strates B.S. Bone morphogenetic protein. J Dent Res 1971, 50:1392-1406.
4. Cho T.J., Gerstenfeld L.C., Einhorn T.A. Differential temporal expression of members of the transforming growth factor β superfamily during murine fracture healing. J Bone Miner Res 2002, 17:513-520.
5. Shen B., Wei A., Whittaker S., Williams L.A., Tao H., Ma D.D., et al. The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro. J Cell Biochem 2010, 109:406-416.
6. Burkus J.K., Heim S.E., Gornet M.F., Zdeblick T.A. The effectiveness of rhBMP-2 in replacing autograft: an integrated analysis of three human spine studies. Orthopedics 2004, 27:723-728.
7. Kang Q., Sun M.H., Cheng H., Peng Y., Montag A.G., Deyrup A.T., et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gen Ther 2004, 11:1312-1320.
8. Zhang W., Deng Z.L., Chen L., Zuo G.W., Luo Q., Shi Q. Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS ONE 2010, 5:e11917.
9. Luther G., Wagner E.R., Zhu G., Kang Q., Luo Q., Lamplot J., et al. BMP-9 induced osteogenic differentiation of mesenchymal stem cells: Molecular mechanism and therapeutic potential. Curr Gene Ther 2011, 11:229-240.
10. Mikami Y., Asano M., Honda M.J., Takagi M. Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cells. J Cell Physiol 2010, 223:123-133.
11. Celeste A.J., Song J.J., Cox K., Rosen V., Wozney J.M. Bone morphogenetic protein-9, a new member of the TGF-β superfamily. J Bone Miner Res 1994, 1:S136.
12. Osada M., Inoue O., Ding G., Shirai T., Ichise H., Hirayama K., et al. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. J Biol Chem 2012, 287:22241-22252.
13. Bidart M., Ricard N., Levet S., Samson M., Mallet C., David L., et al. BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain. Cell Mol Life Sci 2012, 69:313-324.
14. Suttapreyasri S., Koontongkaew S., Phongdara A., Leggat U. Expression of bone morphogenetic proteins in normal human intramembranous and endochondral bone. Int J Oral Maxillofac Surg 2006, 35:444-452.
15. David L., Mallet C., Mazerbourg S., Feige J.J., Bailly S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 2007, 109:1953-1961.
16. Luo J., Tang M., Huang J., He B.C., Gao J.L., Chen L., et al. TGFβ/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J Biol Chem 2010, 285:29588-29598.
17. Miyazono K. Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 1999, 25:91-93.
18. Matsubara T., Kida K., Yamaguchi A., Hata K., Ichida F., Meguro H., et al. BMP2 regulates osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 2008, 283:29119-29125.
19. Jun J.H., Yoon W.J., Seo S.B., Woo K.M., Kim G.S., Ryoo H.M., et al. BMP2-activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels an histone acetyltransferase activity. J Biol Chem 2010, 285:36410-36419.
20. Guicheux J., Lemonnier J., Ghayor C., Suzuki A., Palmer G., Caverzasio J. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res 2003, 18:2060-2068.
21. Tang N., Song W.X., Luo J., Luo X., Chen J., Sharff K.A., et al. BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β-catenin signalling. J Cell Mol Med 2009, 13:2448-2464.
22. van Amerongen R., Nusse R. Towards an integrated view of Wnt signaling in development. Development 2009, 136:3205-3214.
23. Mann B., Gelos M., Siedow A., Hanski M.L., Gratchev A., Ilyas M., et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A 1999, 96:1603-1608.
24. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001, 107:513-523.
25. Boyden L.M., Mao J., Belsky J., Mitzner L., Farhi A., Mitnick M.A., et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 2002, 346:1513-1521.
26. Wojtowicz A.M., Shekaran A., Oest M.E., Dupont K.M., Templeman K.L., Hutmacher D.W., et al. Coating of biomaterial scaffolds with the collagen-mimetic peptide GFOGER for bone defect repair. Biomaterials 2010, 31:2574-2582.
27. Zhang H., Lin C.-Y., Hollister S.J. The interaction between bone marrow stromal cells and RGD-modified three-dimensional porous polycaprolactone scaffolds. Biomaterials 2009, 30:4063-4069.
28. Drevelle O., Bergeron E., Senta H., Lauzon M.-A., Roux S., Grenier G., et al. Effect of polycaprolactone on the behaviour of murine preosteoblasts. Biomaterials 2010, 31:6468-6476.
29. Marquis M.E., Lord E., Bergeron E., Bourgoin L., Faucheux N. Short-term effects of adhesion peptides on the responses of preosteoblasts to pBMP-9. Biomaterials 2008, 29:1005-1016.
30. Rezania A., Healy K.E. Biomimetic peptide surfaces that regulates adhesion, spreading, cytoskeletal organization, and mineralization of the matrix deposited by osteoblast-like cells. Biotechnol Prog 1999, 15:19-32.
31. Lai C.-F., Cheng S.-L. αvβ integrins play an essential role in BMP-2 induction of osteoblast differentiation. J Bone Miner Res 2005, 20:330-340.
32. Massague J., Seoane J., Wotton D. Smad transcription factors. Genes Dev 2005, 19:2783-2810.
33. Heining E., Bhushan R., Paarmann P., Henis Y.I., Knaus P. Spatial segregation of BMP/Smad signaling affects osteoblast differentiation in C2C12 cells. PLoS ONE 2011, 6:e25163.
34. Park J.E.S., Shao D., Upton P.D., deSouza P., Adcock I.M., Davies R.J., et al. BMP-9 induced endothelial cell tubule formation and inhibition of migration involves Smad1 driven endothelin-1 production. PLoS ONE 2012, 7:e3007.
35. Ruppert R., Hoffmann E., Sebald W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem 1996, 237:295-302.
36. Xiao G., Gopalakrishnan R., Jiang D., Reith E., Benson M.D., Franceschi R.T. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 2002, 17:101-110.
37. Bergeron E., Senta H., Mailloux M., Park H., Lord E., Faucheux N. Murine preosteoblast differentiation induced by a peptide derived from bone morphogenetic proteins-9. Tissue Eng Part A 2009, 15:3341-3349.
38. Rezania A., Healy K.E. Integrin subunits responsible for adhesion of human osteoblast-like cells to biomimetic peptide surfaces. J Orthop Res 1999, 17:615-623.
39. Xu D.J., Zhao Y.Z., Wang J., He J.W., Weng Y.G., Luo J.Y. Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. BMB Rep 2012, 45:247-252.
40. Nakashima A., Katagiri T., Tamura M. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. J Biol Chem 2005, 280:37660-37668.
41. Cho Y.D., Kim W.J., Yoon W.J., Woo K.M., Baek J.H., Lee G., et al. Wnt3a stimulates MEPE, matrix extracellular phosphoglycoprotein, expression directly by the activation of the canonical Wnt signaling pathway and indirectly through the stimulation of autocrine Bmp-2 expression. J Cell Physiol 2012, 227:2287-2296.
42. Zhang M., Yan Y., Lim Y.B., Tang D., Xie R., Chen A., et al. BMP-2 modulates β-catenin signaling through stimulation of LRP5 expression and inhibition of β-TrCP expression in osteoblasts. J Cell Biochem 2009, 108:896-905.